...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: OTC Expert & Grey Market Restrictions
Reply New Message
Prev Message Back To Forum Threaded View Next Message

As I recall, DM wasn't happy that ZHCLF started trading on the OTC.  Can't blame them.  It had to be making private placements more difficult.  It's been great for folks who wanted to pick up some cheap shares. And now it looks like we wait for a deal or buyout and hope they put some $$$ in our pockets.

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply